Bayesian Capital Management’s Colgate-Palmolive CL Stock Holding History

Bayesian Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,600	Closed	-$964K	–	571
2025 Q2	$964K	Buy	+10,600	New	+$968K	0.15%	182
2024 Q3	–	Sell	-3,780	Closed	-$367K	–	725
2024 Q2	$367K	Buy	+3,780	New	+$349K	0.04%	454
2024 Q1	–	Sell	-14,796	Closed	-$1.18M	–	814
2023 Q4	$1.18M	Buy	+14,796	New	+$1.11M	0.13%	201
2023 Q3	–	Sell	-47,300	Closed	-$3.64M	–	732
2023 Q2	$3.64M	Buy	+47,300	New	+$3.66M	0.39%	45
2022 Q4	–	Sell	-3,200	Closed	-$225K	–	813
2022 Q3	$225K	Sell	3,200 -23,664	-88%	-$1.86M	0.05%	497
2022 Q2	$2.15M	Buy	+26,864	New	+$2.1M	0.4%	37
2021 Q4	–	Sell	-29,900	Closed	-$2.26M	–	398
2021 Q3	$2.26M	Sell	29,900 -10,861	-27%	-$862K	0.65%	26
2021 Q2	$3.32M	Buy	40,761 +22,561	+124%	+$1.84M	0.87%	22
2021 Q1	$1.44M	Buy	+18,200	New	+$1.43M	0.33%	77
2020 Q4	–	Sell	-33,200	Closed	-$2.56M	–	480
2020 Q3	$2.56M	Sell	33,200 -15,600	-32%	-$1.19M	0.63%	29
2020 Q2	$3.58M	Buy	48,800 +32,600	+201%	+$2.32M	0.79%	16
2020 Q1	$1.07M	Buy	+16,200	New	+$1.14M	0.23%	113
2016 Q4	–	Sell	-6,254	Closed	-$464K	–	608
2016 Q3	$464K	Buy	+6,254	New	+$462K	0.3%	115

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bayesian Capital Management's CL Position: Q3 2025 in Review

Bayesian Capital Management sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 10,600 shares — an estimated $964K sold.

Bayesian Capital Management first reported a position in CL in Q3 2016 and held it in 13 quarters. The position peaked at $3.64M in Q2 2023. 1,845 funds tracked by Wall St. Rank hold CL as of Q3 2025.

Bayesian Capital Management reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
Bayesian Capital Management sold 10,600 Colgate-Palmolive shares in Q3 2025, an estimated $964K.
Bayesian Capital Management first reported a position in Colgate-Palmolive in Q3 2016 and held it in 13 quarters.
Bayesian Capital Management's Colgate-Palmolive position peaked at $3.64M in Q2 2023.
1,845 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.